NASDAQ
Emergent BioSolutions Inc. (EBS) has a current ratio of 5.01x as of Monday, May 25, 2026. This represents a 120.03% increase compared to its 12-month average of 2.28x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.